India  

Serum Institute seeks DCGI's approval for Covishield as booster dose

IndiaTimes Wednesday, 1 December 2021
0
shares
ShareTweetSavePostSend
 

💡 newsR Knowledge: Other News Mentions

Serum Institute of India Serum Institute of India Indian biotechnology and biopharmaceuticals company

Covovax should be India's booster shot, says top govt scientist | Oneindia News [Video]

Covovax should be India's booster shot, says top govt scientist | Oneindia News

On a day that the WHO granted emergency use authorisation to the SII manufactured Covovax, top government scientist Anurag Agrawal said that it should be rolled out as a Covid booster shot. #Omicron #BoosterShot #Covovax

Credit: Oneindia    Duration: 02:01Published
Covovax approved by WHO, SII CEO Adar Poonawalla calls it milestone | Oneindia News [Video]

Covovax approved by WHO, SII CEO Adar Poonawalla calls it milestone | Oneindia News

The World Health Organisation (WHO) on Friday issued an emergency use listing for Covovax, Serum Institute of India's version of Novavax Inc's Covid-19 vaccine. Delhi University is set to adopt a common entrance test for undergraduate admissions from 2022, giving a relief to students from sky high cut off marks; Congress leader Priyanka Gandhi Vadra said she "wholeheartedly condemns" the statement of the Karnataka Congress MLA who stirred a massive outrage making 'indefensible' comments on rape. All this and more news at 9 PM. #DUentrance #Covovax #PriyankaGandhi

Credit: Oneindia    Duration: 03:20Published
India’s GDP grows by 8.4% in the second quarter of Financial Year 2021-22 | Oneindia News [Video]

India’s GDP grows by 8.4% in the second quarter of Financial Year 2021-22 | Oneindia News

India’s GDP grows by 8.4% in July-September; Adar Poonawalla said that children in India should be vaccinated with the Covovax coronavirus vaccine; A new study in the Lancet indicates that the Covishield vaccine against coronavirus remained effective during the Delta variant outbreak; CM Basavaraj Bommai said that the Karnataka government is not looking at any proposal for a statewide lockdown in the wake of the Omicron threat. #GDP #India #Omicron India's GDP grows by 8.4%, Financial Year 2021-22, India’s economic growth, Serum Institute CEO Adar Poonawalla, Covovvax, Vaccination children, Covishield, Lancet study, Delta variant outbreak, Omicron alert, Karnataka CM Basavaraj Bommai, Karnataka government.

Credit: Oneindia    Duration: 02:27Published

Drugs Controller General of India Drugs Controller General of India Director of CDSCO

Daily Tarot Card Reading: How to Unlock and Use the Power of Your Subconscious Mind | Oneindia News [Video]

Daily Tarot Card Reading: How to Unlock and Use the Power of Your Subconscious Mind | Oneindia News

The Drugs Controller General of India has approved Bharat Biotech’s Covid 19 vaccines Covaxin for emergency use on children between the ages of 12 and 18. #Covaxin #VaccineforChildren #BharatBiotech

Credit: Oneindia    Duration: 09:12Published
Covaxin approved for children between the age of 12 to 15 years by DGGI | Oneindia News [Video]

Covaxin approved for children between the age of 12 to 15 years by DGGI | Oneindia News

The Drugs Controller General of India has approved Bharat Biotech’s Covid 19 vaccines Covaxin for emergency use on children between the ages of 12 and 18. #Covaxin #VaccineforChildren #BharatBiotech

Credit: Oneindia    Duration: 01:38Published

Oxford–AstraZeneca COVID-19 vaccine Oxford–AstraZeneca COVID-19 vaccine Viral vector vaccine for prevention of COVID-19 by Oxford University and AstraZeneca

You Might Like


Related news from verified sources

Serum Institute seeks DCGI’s approval for Covishield as booster dose: report


Indian Express

As Omicron fear intensifies, Serum Institute of India seeks DCGI's approval for Covishield booster shot

Recently, Kerala, Rajasthan, Karnataka, and Chhattisgarh have also urged the Centre to decide on allowing booster doses of the COVID-19 vaccine.
DNA

Third jab soon? Serum Institute asks DCGI to allow Covishield as booster dose

SII cited adequate stock of the vaccine in the country and a demand for a booster.
Zee News